Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Several food items and multiple sclerosis: A case-control study in Ahvaz (Iran).
When structure-affinity relationships meet structure-kinetics relationships: 3-((Inden-1-yl)amino)-1-isopropyl-cyclopentane-1-carboxamides as CCR2 antagonists.
Dickkopf-3, a tissue-derived modulator of local T-cell responses.
School performance as a marker of cognitive decline prior to diagnosis of multiple sclerosis.
The role of IL-17 in CNS diseases.
Fingolimod in relapsing multiple sclerosis: An integrated analysis of safety findings.
Induction of atypical EAE mediated by transgenic production of IL-6 in astrocytes in the absence of systemic IL-6.
Improving adherence to injectable disease-modifying drugs in multiple sclerosis.
Dimethyl fumarate : a Janus-faced substance?
Physical and social environment and the risk of multiple sclerosis.
Bone mineral density and body composition in men with multiple sclerosis chronically treated with low-dose glucocorticoids.
Is It Too Early to Predict the Failure of Natalizumab in NMO?-Reply.
Antibodies to MOG in NMO: A seasoned veteran finds a new role.
Alterations of juxtaparanodal domains in two rodent models of CNS demyelination.
Oligodendroglia metabolically support axons and maintain structural integrity.
Regulatory T cell proliferative potential is impaired in human autoimmune disease.
Step-rate thresholds for physical activity intensity in persons with multiple sclerosis.
Sources of information and behavioral patterns in online health forums: qualitative study.
Low prevalence of human herpesvirus-6 and varicella zoster virus in blood of multiple sclerosis patients, irrespective of inflammatory status or disease progression.
Association between neuromyelitis optica and tuberculosis in a Chinese population.
The impact of neuromyelitis optica on the recognition of emotional facial expressions: A preliminary report.
Individualized rituximab treatment for relapsing neuromyelitis optica: a pediatric case report.
First-ever optic neuritis: distinguishing subsequent neuromyelitis optica from multiple sclerosis.
[Case of neuromyelitis optica].
In vivo-generated antigen-specific regulatory T cells treat autoimmunity without compromising antibacterial immune response.
Pages
« first
‹ previous
…
407
408
409
410
411
412
413
414
415
…
next ›
last »